Insider Trading Summary for ISIS Pharmaceuticals Inc. (IONS): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
17-Jul-24 5:03 PM View:	15-Jul-24 Option Exercise Duplicate 0	Wender Joseph H Director		ISIS Pharmaceuticals Inc. - IONS	18% 112.08K to 132.76K	0	0	--	--	Show Txns Hide Txns

17-Jul-24 5:02 PM View:	15-Jul-24 Option Exercise 0	Berthelsen Spencer R Director		ISIS Pharmaceuticals Inc. - IONS	3% 147.33K to 152.0K	0	0	--	--	Show Txns Hide Txns

17-Jul-24 5:02 PM View:	16-Jul-24 Planned Option Sale ($600.00K)	Klein Joseph III Director		ISIS Pharmaceuticals Inc. - IONS	(27%) 22.45K to 16.45K	0	0	--	--	Show Txns Hide Txns

17-Jul-24 5:03 PM View:	15-Jul-24 Option Exercise 0	Parshall B Lynne Director		ISIS Pharmaceuticals Inc. - IONS	6% 82.59K to 87.27K	0	0	--	--	Show Txns Hide Txns

17-Jul-24 5:02 PM View:	15-Jul-24 Option Exercise 0	Herman Joan E Director		ISIS Pharmaceuticals Inc. - IONS	13% 37.33K to 42.01K	0	0	--	--	Show Txns Hide Txns

02-Feb-24 7:55 PM View:	02-Feb-24 Sale ($105.27K)	Hougen Elizabeth L EVP, Finance & CFO		ISIS Pharmaceuticals Inc. - IONS	23% 75.66K to 92.91K	0	0	--	--	Show Txns Hide Txns

17-Jul-24 5:02 PM View:	16-Jul-24 Planned Option Sale ($81.02K)	Diaz Allene M. Director		ISIS Pharmaceuticals Inc. - IONS	24% 12.68K to 15.72K	0	0	--	--	Show Txns Hide Txns

04-Sep-24 9:43 PM View:	30-Aug-24 Acquisition (other) $9.51K	O'Neil Patrick R. EVP CLO & General Counsel		ISIS Pharmaceuticals Inc. - IONS	21% 40.35K to 48.87K	0	0	--	--	Show Txns Hide Txns

17-Apr-24 5:19 PM View:	16-Apr-24 Option Sale ($166.64K)	Baroldi Joseph EVP, Chief Business Officer		ISIS Pharmaceuticals Inc. - IONS	86% 11.42K to 21.27K	0	0	--	--	Show Txns Hide Txns

02-Feb-24 7:55 PM View:	02-Feb-24 Sale ($102.70K)	Schneider Eugene EVP, Chf Clinical Develop Ofcr		ISIS Pharmaceuticals Inc. - IONS	38% 36.05K to 49.81K	0	0	--	--	Show Txns Hide Txns

02-Feb-24 7:54 PM View:	02-Feb-24 Sale ($105.40K)	Cadoret-Manier Onaiza EVP,Chf GL Pdt Str & Oper Ofc		ISIS Pharmaceuticals Inc. - IONS	47% 24.31K to 35.83K	0	0	--	--	Show Txns Hide Txns

04-Sep-24 9:40 PM View:	30-Aug-24 Acquisition (other) $0.46K	Birchler Brian EVP, Corp and Development Ops		ISIS Pharmaceuticals Inc. - IONS	26% 36.53K to 46.17K	0	0	--	--	Show Txns Hide Txns

14-Nov-24 5:30 PM View:	12-Nov-24 Private Sale (Planned) ($511.43K)	Loscalzo Joseph Director		ISIS Pharmaceuticals Inc. - IONS	(21%) 41.08K to 32.25K	0	0	--	--	Show Txns Hide Txns

04-Sep-24 9:41 PM View:	30-Aug-24 Acquisition (other) $0.43K	Geary Richard S EVP, Chief Development Officer		ISIS Pharmaceuticals Inc. - IONS	16% 72.96K to 84.83K	0	0	--	--	Show Txns Hide Txns

04-Sep-24 9:40 PM View:	30-Aug-24 Acquisition (other) $6.84K	Bennett C Frank EVP, Chief Scientific Officer		ISIS Pharmaceuticals Inc. - IONS	21% 65.75K to 79.61K	0	0	--	--	Show Txns Hide Txns

14-Nov-24 5:30 PM View:	12-Nov-24 Private Sale (Planned) ($252.29K)	Monia Brett P Chief Executive Officer Director		ISIS Pharmaceuticals Inc. - IONS	42% 118.11K to 167.39K	0	0	--	--	Show Txns Hide Txns

14-Nov-24 5:30 PM View:	12-Nov-24 Private Sale (Planned) ($45.28K)	Swayze Eric EVP Research		ISIS Pharmaceuticals Inc. - IONS	4% 32.59K to 33.87K	0	0	--	--	Show Txns Hide Txns

ISIS Pharmaceuticals Inc. (IONS)

Last Year

23-Nov-23 -- 22-Nov-24

Company Sentiment

Drug Manufacturers - Other

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	0	--